US OptionsDetailed Quotes
REPL250117P12500
- 0.90
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.90Open0.90Pre Close0 Volume20 Open Interest12.50Strike Price0.00Turnover164.47%IV-3.57%PremiumJan 17, 2025Expiry Date1.30Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6040Delta0.1266Gamma5.53Leverage Ratio-0.0591Theta-0.0022Rho-3.34Eff Leverage0.0071Vega
Replimune Stock Discussion
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
No comment yet